Invaio Sciences announces acquisition of Peptyde Bio
Invaio Sciences has acquired Peptyde Bio to bring an established platform and IP portfolio enabling Invaio to speed up the design and discovery of peptides
Stay updated with breaking news from Peptyde Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Invaio Sciences has acquired Peptyde Bio to bring an established platform and IP portfolio enabling Invaio to speed up the design and discovery of peptides
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
He built a name for himself apart from his famous family—and defied VC expectations
Peptyde Bio is the first company spun out of the Donald Danforth Plant Science Center by Danforth Technology Company (DTC) , the wholly-owned subsidiary formed by the Danforth Center in February 2022 .
Press release content from Business Wire. The AP news staff was not involved in its creation.